Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News   Featured News   Commencing the Commercialization of Cannabis...

Commencing the Commercialization of Cannabis-infused Oral Thin Strips

Stockhouse Editorial
0 Comments| June 13, 2019
{{labelSign}}  Favorites
{{errorMessage}}
Rapid Dose Therapeutics Corp. (CSE: DOSE, Forum) and partner Chemesis International Inc. have announced they have initiated commercialization of QuickStrip™Oral Thin Strips – a sublingual delivery device for THC, CBD, and other cannabinoids.

For more information on the announcement, click here.


FULL DISCLOSURE: Rapid Dose Therapeutics Corp. is a paid client of Stockhouse Publishing.

{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today